Cargando…

Correction: Regulation of p53 Level by UBE4B in Breast Cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395164/ https://www.ncbi.nlm.nih.gov/pubmed/25875638 http://dx.doi.org/10.1371/journal.pone.0125136

Ejemplares similares

Correction: Regulation of p53 Level by UBE4B in Breast Cancer
Publicado: (2014)

Regulation of p53 Level by UBE4B in Breast Cancer
por: Zhang, Ying, et al.
Publicado: (2014)

Correction: UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2023)

UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
por: Du, Cheng, et al.
Publicado: (2015)

The SWIB/MDM2 motif of UBE4B activates the p53 pathway
por: Wu, H. Helena, et al.
Publicado: (2023)

Correction to: DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5
por: Wang, Liang, et al.
Publicado: (2022)

Correction: The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner
por: Arsic, Nikola, et al.
Publicado: (2017)

Regulation of Protein Quality Control by UBE4B and LSD1 through p53-Mediated Transcription
por: Periz, Goran, et al.
Publicado: (2015)

Publisher Correction: UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation
por: Subramanian, Manivannan, et al.
Publicado: (2021)

Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53
por: Weng, Chengyin, et al.
Publicado: (2019)

Correction: UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells
por: Falvey, Chloe M., et al.
Publicado: (2020)

Correction: Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53
por: Page, Angustias, et al.
Publicado: (2017)

UBE2N Regulates Paclitaxel Sensitivity of Ovarian Cancer via Fos/P53 Axis
por: Zhu, Qiuyuan, et al.
Publicado: (2020)

Correction to: High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis
por: Yang, Chen, et al.
Publicado: (2022)

Correction to: M1 macrophage dependent-p53 regulates the intracellular survival of mycobacteria
por: Lim, Yun-Ji, et al.
Publicado: (2019)

Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2012)

Correction: Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
por: Wang, Guihua, et al.
Publicado: (2021)

Correction: p53 and metabolism: from mechanism to therapeutics
por: Simabuco, Fernando M., et al.
Publicado: (2018)

SF3B4 Depletion Retards the Growth of A549 Non-Small Cell Lung Cancer Cells via UBE4B-Mediated Regulation of p53/p21 and p27 Expression
por: Kim, Hyungmin, et al.
Publicado: (2022)

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Correction to: Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment
por: Singh, Sandeep, et al.
Publicado: (2020)

Correction: The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA–RNA interactions and drives gastric cancer metastasis via miR-138-5p/ITGA2 axis
por: Li, Dandan, et al.
Publicado: (2023)

Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study
por: Dave, Rajiv V., et al.
Publicado: (2021)

Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
por: Zhao, Kai, et al.
Publicado: (2019)

Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study
por: Dave, Rajiv V., et al.
Publicado: (2021)

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
por: Costa, Caterina, et al.
Publicado: (2020)

Correction: MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity
por: Chinnam, Meenalakshmi, et al.
Publicado: (2022)

Correction: Tumor Suppressor p53 Functions as a Negative Regulator in IgE-Mediated Mast Cell Activation
Publicado: (2014)

Correction: RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC
por: Majumder, Mrinmoyee, et al.
Publicado: (2016)

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2019)

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
por: Ge, Yuanlong, et al.
Publicado: (2019)

Correction to: The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
por: Yan, Yu, et al.
Publicado: (2022)

Correction: Phytometabolite Dehydroleucodine Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Human Astrocytoma Cells through p73/p53 Regulation
por: Bailon-Moscoso, Natalia, et al.
Publicado: (2017)

Correction: miR-30 Regulates Mitochondrial Fission through Targeting p53 and the Dynamin-Related Protein-1 Pathway
por: Li, Jincheng, et al.
Publicado: (2010)

Correction: Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes
por: Chual, Su-Kiat, et al.
Publicado: (2016)

Correction to: ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation
por: Castro, María Victoria, et al.
Publicado: (2022)

Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
por: Lin, Shu, et al.
Publicado: (2022)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Correction: Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3ibvf32kmo8k89qiemu16ov3jd